Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Paris (France), December 12th, 2017 – Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, today announced the appointment of Dr. Patricia Zilliox as CEO. Dr.…